Our findings could provide a mechanistic link between cancer progression [35] and cardiovascular disease, particularly highlighting how TGF-β-enriched vesicles may simultaneously promote melanoma aggressiveness and induce metabolic cardiomyocyte changes, as well as adverse atherogenic stimuli and non-ischemic cardiac fibrosis in the cardiovascular system. Here, TGFB1 is linked to cancer.